Measurement of Proliferation and Disappearance of Regulatory T Cells in Human Studies Using Deuterium-Labeled Glucose

Methods in Molecular Biology

Volumn 707, Issue , 2011, Pages 243-261

  Vukmanovic Stejic, Milica ^a   Zhang, Yan ^b   Akbar, Arne N ^a   Macallan, Derek C ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Death; Isotope; Kinetics; Lymphocyte; Proliferation; Regulatory T cell; Tracer; Treg

Indexed keywords

DEUTERIUM; GLUCOSE;

ARTICLE; BIOLOGICAL MODEL; CELL PROLIFERATION; CYTOLOGY; HUMAN; ISOTOPE LABELING; METABOLISM; METHODOLOGY; REGULATORY T LYMPHOCYTE;

CELL PROLIFERATION; DEUTERIUM; GLUCOSE; HUMANS; ISOTOPE LABELING; MODELS, BIOLOGICAL; T-LYMPHOCYTES, REGULATORY;

EID: 79955685447     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-61737-979-6_16     Document Type: Chapter

References (36)

1. Sakaguchi S, Yamaguchi T, Nomura T, Ono M. (2008) Regulatory T cells and immune tolerance. Cell 133, 775–787.
2. Maloy KJ, Powrie F. (2001) Regulatory T cells in the control of immune pathology. Nat. Immunol. 2, 816–822.
3. Shevach EM. (2000) Regulatory T cells in autoimmmunity. Annu. Rev. Immunol. 18, 423–449.
4. Pan F, Yu H, Dang EV et al. (2009) Eos mediates Foxp3-dependent gene silencing in CD4+ regulatory T cells. Science 325,1142–1146.
5. Peng G, Li S, Wu W, Sun Z, Chen Y, Chen Z. (2008) Circulating CD4+ CD25+ regulatory T cells correlate with chronic hepatitis B infection. Immunology 123, 57–65.
6. Rushbrook SM, Ward SM, Unitt E et al. (2005) Regulatory T cells suppress in vitro proliferation of virus-specific CD8+ T cells during persistent hepatitis C virus infection. J. Virol. 79, 7852–7859.
7. Jeron A, Pfoertner S, Bruder D et al. (2009) Frequency and gene expression profile of regulatory T cells in renal cell carcinoma. Tumour Biol. 30, 160–170.
8. Asquith B, Debacq C, Macallan DC, Willems L, Bangham C. (2002) Lymphocyte kinetics: the interpretation of labelling data. Trends Immunol. 23, 596–601.
9. Macallan DC, Asquith B, Irvine A et al. (2003) Measurement and modeling of human T cell kinetics. Eur. J. Immunol. 33, 2316–2326.
10. Asquith B, Borghans JA, Ganusov VV, Macallan DC. (2009) Lymphocyte kinetics in health and disease. Trends Immunol. 30, 182–189.
11. Vukmanovic-Stejic M, Zhang Y, Cook JE et al. (2006) Human CD4+ CD25hi Foxp3+ regulatory T cells are derived by rapid turnover of memory populations in vivo. J. Clin. Invest. 116, 2423–2433.
12. Busch R, Neese RA, Awada M, Hayes GM, Hellerstein MK. (2007) Measurement of cell proliferation by heavy water labeling. Nat. Protoc. 2, 3045–3057.
13. Hellerstein MK. (1999) Measurement of T-cell kinetics: recent methodologic advances. Immunol. Today 20, 438–441.
14. Tough DF, Sprent J. (1994) Turnover of naive-and memory-phenotype T cells. J. Exp. Med. 179, 1127–1135.
15. Kovacs JA, Lempicki RA, Sidorov IA et al. (2001) Identification of dynamically distinct subpopulations of T lymphocytes that are dif-ferentially affected by HIV. J. Exp. Med. 194, 1731–1741.
16. Schwarting R, Gerdes J, Niehus J, Jaeschke L, Stein H. (1986) Determination of the growth fraction in cell suspensions by flow cytometry using the monoclonal antibody Ki-67. J. Immunol. Methods 90, 65–70.
17. Quah BJ, Warren HS, Parish CR. (2007) Monitoring lymphocyte proliferation in vitro and in vivo with the intracellular fluorescent dye carboxyfluorescein diacetate succinimidyl ester. Nat. Protoc. 2, 2049–2056.
18. Hawkins ED, Hommel M, Turner ML, Battye FL, Markham JF, Hodgkin PD. (2007) Measuring lymphocyte proliferation, survival and differentiation using CFSE time-series data. Nat. Protoc. 2, 2057–2067.
19. Lyons AB. (2000) Analysing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution. J. Immunol. Methods 243, 147–154.
20. Macallan DC, Fullerton CA, Neese RA, Haddock K, Park S, Hellerstein MK. (1998) Measurement of cell proliferation by labeling of DNA with stable isotope-labeled glucose: Studies in vitro, in animals and in humans. Proc. Natl. Acad. Sci. USA 95, 708–713.
21. Macallan DC, Wallace DL, Irvine A et al. (2003) Rapid turnover of T cells in acute infectious mononucleosis. Eur. J. Immunol. 33, 2655–2665.
22. Macallan DC, Wallace D, Zhang Y et al. (2004) Rapid turnover of effector-memory CD4(+) T cells in healthy humans. J. Exp. Med. 200, 255–260.
23. Wallace DL, Zhang Y, Ghattas H et al. (2004) Direct measurement of T cell subset kinetics in vivo in elderly men and women. J. Immunol. 173, 1787–1794.
24. Macallan DC, Wallace DL, Zhang Y et al. (2005) B cell kinetics in humans: rapid turnover of peripheral blood memory cells. Blood 105, 3633–3640.
25. Defoiche J, Debacq C, Asquith B et al. (2008) Reduction of B cell turnover in chronic lym-phocytic leukaemia. Br. J. Haematol. 143, 240–247.
26. Hellerstein M, Hanley MB, Cesar D et al. (1999) Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans. Nat. Med. 5, 83–89.
27. Hellerstein MK, Hoh RA, Hanley MB et al. (2003) Subpopulations of long-lived and short-lived T cells in advanced HIV-1 infection. J. Clin. Invest. 112, 956–966.
28. McCune JM, Hanley MB, Cesar D et al. (2000) Factors influencing T-cell turnover in HIV-1-seropositive patients. J. Clin. Invest. 105, R1–R8.
29. Kovacs JA, Lempicki RA, Sidorov IA et al. (2005) Induction of prolonged survival of CD4+ T lymphocytes by intermittent IL-2 therapy in HIV-infected patients. J. Clin. Invest. 115, 2139–2148.
30. Read SW, Lempicki RA, Mascio MD et al. (2008) CD4 T cell survival after intermittent interleukin-2 therapy is predictive of an increase in the CD4 T cell count of HIV-infected patients. J. Infect. Dis. 198, 843–850.
31. Macallan DC, Asquith B, Zhang Y et al. (2009) Measurement of proliferation and disappearance of rapid turnover cell populations in human studies using deuterium-labelled glucose. Nat. Protoc. 4, 1313–1327.
32. Stevens RA, Lempicki RA, Natarajan V, Higgins J, Adelsberger JW, Metcalf JA. (2006) General immunologic evaluation of patients with human immunodeficiency virus infection. In: Detrick B, Hamilton RG, Folds JD, editors. Manual of molecular and clinical laboratory immunology. Washington, DC: ASM, 848–861.
33. Fox SD, Lempicki RA, Hosack DA et al. (2003) A comparison of microLC/electro-spray ionization-MS and GC/MS for the measurement of stable isotope enrichment from a [2H2]-glucose metabolic probe in T-cell genomic DNA. Anal. Chem. 75, 6517–6522.
34. Vrisekoop N, den Braber I, de Boer AB et al. (2008) Sparse production but preferential incorporation of recently produced naive T cells in the human peripheral pool. Proc. Natl. Acad. Sci. USA 105, 6115–6120.
35. Asquith B, Zhang Y, Mosley AJ et al. (2007) In vivo T lymphocyte dynamics in humans and the impact of human T-lymphotropic virus 1 infection. Proc. Natl. Acad. Sci. USA 104, 8035–8040.
36. Borghans JA, De Boer RJ. (2007) Quanti-fication of T-cell dynamics: from telomeres to DNA labeling. Immunol. Rev. 216, 35–47.